eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Reconstructive Surgery
Drooling: Workup
Updated: Nov 12, 2008
Workup
Laboratory Studies
- Salivary flow rate (mL/min): increase in weight of dental rolls/time of collection The absorbent dental rolls can be kept directly at the orifices of large salivary glands
- Drooling Quotient : 40 observations in 10 minutes (every 15 minutes) DQ% = 100 x number of drooling episodes/40
- Teacher Drooling Scale: 1-5 1= no drooling3= occasional drooling5= constantly wet saliva leaking on clothes and furniture
Imaging Studies
- Lateral neck film: Adenoid hypertrophy can be confirmed if the patient has a history of nasal obstruction. Complete the adenoidectomy prior to further surgical intervention to neutralize the effects of mouth breathing on drooling.
- Modified barium swallow: Some authors recommend performing this study to help rule out the contraindications to surgical therapy, including esophageal motility disorders, esophageal spasm, or aspiration.
- Radiosialography: For some authors and for research purposes, these scans using radioisotope are useful for evaluating the secretory function of the salivary gland when assessing the success of surgical therapy.
Other Tests
- Audiogram: Perform this study on patients being considered for tympanic neurectomy or chorda tympani nerve section because unilateral hearing impairment is a contraindication because of the risk of hearing loss associated with the procedures.
- Flexible nasopharyngoscopy: This is an alternative method to assess the amount of adenoid tissue if the patient has history findings suggestive of nasal obstruction.
More on Drooling |
| Overview: Drooling |
Workup: Drooling |
| Treatment: Drooling |
| Multimedia: Drooling |
| References |
| « Previous Page | Next Page » |
References
Jongerius PH, van Hulst K, van den Hoogen FJ, et al. The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy. J Pediatr Gastroenterol Nutr. Sep 2005;41(3):351-3. [Medline].
von Lindern JJ, Niederhagen B, Appel T, et al. New prospects in the treatment of traumatic and postoperative parotid fistulas with type A botulinum toxin. Plast Reconstr Surg. Jun 2002;109(7):2443-5. [Medline].
Laskawi R, Drobik C, Schönebeck C. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome). Laryngoscope. Mar 1998;108(3):381-4. [Medline].
Lim YC, Choi EC. Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment. Eur Arch Otorhinolaryngol. Feb 2008;265(2):243-5. [Medline].
Manrique D. Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis. Braz J Otorhinolaryngol. Sep-Oct 2005;71(5):566-9. [Medline].
Costa J, Rocha ML, Ferreira J, et al. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis. J Neurol. Apr 2008;255(4):545-50. [Medline].
Marina MB, Sani A, Hamzaini AH, et al. Ultrasound-guided botulinum toxin A injection: an alternative treatment for dribbling. J Laryngol Otol. Jun 2008;122(6):609-14. [Medline].
Neppelberg E, Haugen DF, Thorsen L, et al. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis. Eur J Neurol. Dec 2007;14(12):1373-7. [Medline].
Postma AG, Heesters M, van Laar T. Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism. Mov Disord. Dec 2007;22(16):2430-5. [Medline].
Shott SR, Myer CM 3rd, Cotton RT. Surgical management of sialorrhea. Otolaryngol Head Neck Surg. Jul 1989;101(1):47-50. [Medline].
Wilkie TF. The problem of drooling in cerebral palsy: a surgical approach. Can J Surg. Jan 1967;10(1):60-7. [Medline].
Bailey CM, Wadsworth PV. Treatment of the drooling child by submandibular duct transposition. J Laryngol Otol. Nov 1985;99(11):1111-7. [Medline].
Bax M. Drooling. Dev Med Child Neurol. Oct 1992;34(10):847-8. [Medline].
Blasco PA, Allaire JH. Drooling in the developmentally disabled: management practices and recommendations. Consortium on Drooling. Dev Med Child Neurol. Oct 1992;34(10):849-62. [Medline].
Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med. Sep 1996;150(9):932-5. [Medline].
Brundage SR, Moore WD. Submandibular gland resection and bilateral parotid duct ligation as a management for chronic drooling in cerebral palsy. Plast Reconstr Surg. Mar 1989;83(3):443-6. [Medline].
Burton MJ. The surgical management of drooling. Dev Med Child Neurol. Dec 1991;33(12):1110-6. [Medline].
Camp-Bruno JA, Winsberg BG, Green-Parsons AR, et al. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol. Jun 1989;31(3):309-19. [Medline].
Camp-Bruno JA, Winsberg BG, Green-Parsons AR, et al. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol. Jun 1989;31(3):309-19. [Medline].
Camp-Bruno JA, Winsberg BG, Green-Parsons AR, et al. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol. Jun 1989;31(3):309-19. [Medline].
Cotton RT, Richardson MA. The effect of submandibular duct rerouting in the treatment of sialorrhea in children. Otolaryngol Head Neck Surg. Jul-Aug 1981;89(4):535-41. [Medline].
Crysdale WS. Drooling. Experience with team assessment and management. Clin Pediatr (Phila). Feb 1992;31(2):77-80. [Medline].
Crysdale WS. Management options for the drooling patient. Ear Nose Throat J. Nov 1989;68(11):820, 825-6, 829-30. [Medline].
Crysdale WS. The drooling patient: evaluation and current surgical options. Laryngoscope. May 1980;90(5 Pt 1):775-83. [Medline].
Crysdale WS, Gaffney RJ. The management of drooling (Chapter 53). In: Bluestone CD, Stool SE, Kenna MA, eds. Pediatric Otolaryngology. Philadelphia: Saunders; 1996:974-983.
Crysdale WS, White A. Submandibular duct relocation for drooling: a 10-year experience with 194 patients. Otolaryngol Head Neck Surg. Jul 1989;101(1):87-92. [Medline].
Dundas DF, Peterson RA. Surgical treatment of drooling by bilateral parotid duct ligation and submandibular gland resection. Plast Reconstr Surg. Jul 1979;64(1):47-51. [Medline].
Glass LW, Nobel GL, Vecchione TR. Treatment of uncontrolled drooling by bilateral excision of submaxillary glands and parotid duct ligations. Plast Reconstr Surg. Oct 1978;62(4):523-6. [Medline].
Gordon C, Ben-Aryeh H, Attias J, et al. Effect of transdermal scopolamine on salivation. J Clin Pharmacol. Sep 1985;25(6):407-12. [Medline].
Kapila YV, Dodds WJ, Helm JF, et al. Relationship between swallow rate and salivary flow. Dig Dis Sci. Jun 1984;29(6):528-33. [Medline].
Klem C, Mair EA. Four-duct ligation: a simple and effective treatment for chronic aspiration from sialorrhea. Arch Otolaryngol Head Neck Surg. Jul 1999;125(7):796-800. [Medline].
Lespargot A, Langevin MF, Muller S, et al. Swallowing disturbances associated with drooling in cerebral-palsied children. Dev Med Child Neurol. Apr 1993;35(4):298-304. [Medline].
Lew KM, Younis RT, Lazar RH. The current management of sialorrhea. Ear Nose Throat J. Feb 1991;70(2):99-105. [Medline].
Mankarious LA, Bottrill ID, Huchzermeyer PM, et al. Long-term follow-up of submandibular duct rerouting for the treatment of sialorrhea in the pediatric population. Otolaryngol Head Neck Surg. Mar 1999;120(3):303-7. [Medline].
Michel RG, Johnson KA, Patterson CN. Parasympathetic nerve section for control of sialorrhea. Arch Otolaryngol. Feb 1977;103(2):94-7. [Medline].
Pal PK, Calne DB, Calne S, et al. Botulinum toxin A as treatment for drooling saliva in PD. Neurology. Jan 11 2000;54(1):244-7. [Medline].
Parisier SC, Blitzer A, Binder WJ, et al. Tympanic neurectomy and chorda tympanectomy for the control of drooling. Arch Otolaryngol. May 1978;104(5):273-7. [Medline].
Reddihough D, Johnson H, Staples M, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol. Nov 1990;32(11):985-9. [Medline].
Reddihough D, Johnson H, Staples M, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol. Nov 1990;32(11):985-9. [Medline].
Robinson AC, Khoury GG, Robinson PM. Role of irradiation in the suppression of parotid secretions. J Laryngol Otol. Jun 1989;103(6):594-5. [Medline].
Rosen A, Komisar A, Ophir D, et al. Experience with the Wilkie procedure for sialorrhea. Ann Otol Rhinol Laryngol. Sep 1990;99(9 Pt 1):730-2. [Medline].
Scheyer L. Rate of secretion of individual saliva gland pairs under conditions of reduced stimulation. J Appl Physiol. 1955;7:580-2.
Siegel LK, Klingbeil MA. Control of drooling with transdermal scopolamine in a child with cerebral palsy. Dev Med Child Neurol. Nov 1991;33(11):1013-4. [Medline].
Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. Jan 2002;112(1):73-81. [Medline].
Talmi YP, Finkelstein Y, Zohar Y. Reduction of salivary flow with transdermal scopolamine: a four-year experience. Otolaryngol Head Neck Surg. Oct 1990;103(4):615-8. [Medline].
Wilkie TF, Brody GS. The surgical treatment of drooling. A ten-year review. Plast Reconstr Surg. Jun 1977;59(6):791-7. [Medline].
Further Reading
Keywords
drooling, sialorrhea, sialorrhoea, ptyalism, cerebral palsy, cognitive impairment, neurological impairment, neurologic impairment, perioral skin breakdown, perioral skin infection, severe mental retardation, hypersecretion of the salivary glands, salivary gland hypersecretion, dysfunctional voluntary oral motor activity, secretory control of the salivary glands
Workup: Drooling